Shiga Toxin-Producing E. coli and Hemolytic Uremic Syndrome: A Study of the 2022 Outbreak in Turkey

09 December 2024 : Clinical Research

Oğuzhan Zengin

^{ABCDEFG 1*}, Burak Göre

^{ABCDEFG 1}, Oğuz Öztürk

^{ABCDEFG 2}, Muhammet Göv

^{ABCDEFG 1}, Enes Seyda Şahiner

^{ABCDEFG 1}, Osman İnan

^{ABCDEFG 1}, Emra Asfuroğlu Kalkan

^{ABCDEFG 1}, Şimal Kösal Cevher

^{ABCDEFG 3}, Ahmet Kürşad Güneş

^{ABCDEFG 4}, Gülsüm Özet

^{ABCDEFG 5}, İhsan Ateş

^{ABCDEFG 1}

DOI: 10.12659/MSM.946033

Med Sci Monit 2024; 30:e946033

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 The relationship between the history of antibiotic use and laboratory parameters before admission.

On admission	Antibiotic		P
	No	Yes
	Mean±SD	Mean±SD
Hemoglobin (g/dL)	11.49±1.91	11.03±1.01	0.664
Platelet (10/L)	103.846±113.539	102.3±122.3	0.447
White blood count (10/L)	15.477±4.988	17.646±8.301	0.515
Hematocrit (%)	35.07±5.6	33.91±3.52	0.744
Creatinine, (mg/dL)	2.21±1.32	2.56±1.76	0.913
Glomerular filtration rate (m/min/1.73 m)	38.13±24.79	38.76±26.55	0.885
Lactate dehydrogenase (U/L)	925.23±532.96	1241.63±824.82	0.515
Total bilirubin (mg/dL)	1.67±1.03	1.37±1.07	0.405
Indirect bilirubin (mg/dL)	1±0.63	0.92±0.68	0.800
Amylase (U/L)	52.54±27.5	79.13±85.77	0.744
Lipase (U/L)	47.88±29.93	32.13±15.59	0.088
Troponin-I (ng/L)	27.23±43.91	958.73±2478.56	0.119
	2545.92±3103.58	13033.38±14363.23
Analysis conducted with the Mann-Whitney U test. NT-proBNP – N-terminus pro-B-type natriuretic peptide.

Back to the Article